欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
PT/H/1658/001
药品名称
Cinarizina + Dimenidrinato Galenica
活性成分
cinnarizine 20.0 mg
dimenhydrinate 40.0 mg
剂型
Tablet
上市许可持有人
Biofarmoz - Sociedade Técnico Medicinal, Unip. Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Bulgaria (BG)
Cinnarizine + Dimenhydrinate/Galenica 20 mg + 40 mg tablet
Cyprus (CY)
CINNARIZINE+DIMENHYDRINATE GALENICA
Romania (RO)
Greece (GR)
CINNARIZINE+DIMENHYDRINATE/GALENICA
许可日期
2017/07/12
最近更新日期
2023/06/16
药物ATC编码
N07CA52 cinnarizine, combinations
申请类型
TypeLevel1：
Abridged
TypeLevel2：
Initial Application
TypeLevel3：
Generic Art 10.1 and 10.2 Dir 2001/83/EC
TypeLevel4：
Chemical Substance
TypeLevel5：
Prescription Only
附件文件下载
PubAR
|
609181_20170727_PAR_GBB
Date of last change:2024/09/06
Final Product Information
|
Immediate_packaging_cinarizina_dimenidrinato galenica
Date of last change:2024/09/06
Final Product Information
|
Outer_packaging_cinarizina_dimenidrinato galenica
Date of last change:2024/09/06
Final Product Information
|
Package_leaflet_cinarizina_dimenidrinato galenica_clean
Date of last change:2024/09/06
Final Product Information
|
SmPC_cinarizina_dimenidrinato galenica_clean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase